Multidisciplinary surgical treatment of clear-cell renal carcinoma with inferior vena cava tumor thrombus level III and IV: our experience during the past decade

Bibliographic Details
Title: Multidisciplinary surgical treatment of clear-cell renal carcinoma with inferior vena cava tumor thrombus level III and IV: our experience during the past decade
Authors: Tvrtko Hudolin, Vladimir Ferenčak, Luka Penezić, Toni Zekulić, Tomislav Kuliš, Marjan Marić, Oliver Pavlović, Ahmad El-Saleh, Nikola Knežević, Eleonora Goluža, Bojan Biočina, Željko Kaštelan
Source: Libri Oncologici, Vol 48, Iss 2-3, Pp 68-72 (2020)
Publisher Information: University Hospital for Tumors, 2020.
Publication Year: 2020
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: renal cell carcinoma, inferior vena cava, venous thrombosis, radical nephrectomy, cardiopulmonary bypass, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Patients with non-metastatic, stage T3 clear-cell renal cell cancer present a clinical challenge for urologists. The extent of tumor thrombus in inferior vena cava is the primary determinant of surgical procedure complexity. Level III and IV thrombi require the use of cardiopulmonary bypass and hypothermic arrest. Careful preoperative planning and a multidisciplinary approach are mandatory. In this paper, we report outcomes of 12 patients who were surgically treated in our center. The 29 months overall survival for all patients was 69%, while three patients died during follow-up. Of nine surviving patients, six are currently disease-free, whereas three had disease progression. Our study showed that carefully selected patients with clear-cell renal cell carcinoma with inferior vena cava tumor thrombus level III and IV could be successfully treated with an aggressive surgical approach.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 0300-8142
2584-3826
Relation: https://hrcak.srce.hr/file/364240; https://doaj.org/toc/0300-8142; https://doaj.org/toc/2584-3826
DOI: 10.20471/LO.2020.48.02-03.12
Access URL: https://doaj.org/article/a2d965bc5285440e88564df8af85d119
Accession Number: edsdoj.2d965bc5285440e88564df8af85d119
Database: Directory of Open Access Journals
More Details
ISSN:03008142
25843826
DOI:10.20471/LO.2020.48.02-03.12
Published in:Libri Oncologici
Language:English